University of Liverpool: CELT Global Health Part of Initiative to Accelerate Innovation Against Drug-resistant Bacterial Infections
December 18, 2025
December 18, 2025
LIVERPOOL, England, Dec. 18 -- The University of Liverpool issued the following news release:
* * *
CELT Global Health part of new initiative to accelerate innovation against drug-resistant bacterial infections
The University of Liverpool's Centre of Excellence for Long-acting Therapeutics - Global Health (CELT Global Health) is part of a new public-private research initiative called END2AMR (European Novel Drug Research to Address Microbial Infections . . .
* * *
CELT Global Health part of new initiative to accelerate innovation against drug-resistant bacterial infections
The University of Liverpool's Centre of Excellence for Long-acting Therapeutics - Global Health (CELT Global Health) is part of a new public-private research initiative called END2AMR (European Novel Drug Research to Address Microbial Infections . . .